SHENZHEN, China, July 20, 2022 /PRNewswire/ -- ImmVira's global first intravenous ("IV") administered oncolytic herpes simplex virus ("oHSV") product MVR-T3011 IV has completed the first three cohort ...
In the final episode, Overcoming Barriers and Future Integration of Subcutaneous Therapies in Lung Cancer, the panelists ...
Jacob is your community news reporter covering the Santa Maria Valley. Last August, Innerbloom Ketamine opened its doors in San Luis Obispo, offering legal, IV-administered microdoses of ketamine to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results